MedPath
HSA Approval

SALATAZ POWDER FOR SOLUTION FOR INJECTION/INFUSION 4.5G/VIAL

SIN15299P

SALATAZ POWDER FOR SOLUTION FOR INJECTION/INFUSION 4.5G/VIAL

SALATAZ POWDER FOR SOLUTION FOR INJECTION/INFUSION 4.5G/VIAL

July 14, 2017

PAN-MALAYAN PHARMACEUTICALS PTE LTD

PAN-MALAYAN PHARMACEUTICALS PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantPAN-MALAYAN PHARMACEUTICALS PTE LTD
Licence HolderPAN-MALAYAN PHARMACEUTICALS PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

INJECTION, POWDER, FOR SOLUTION

INTRAVENOUS

Medical Information

J01CR05

piperacillin and beta-lactamase inhibitor

Manufacturer Information

PAN-MALAYAN PHARMACEUTICALS PTE LTD

Shandong Anxin Pharmaceutical Co., Ltd. (Intermediate Bulk Drug Product Manufacturer)

Laboratorio Reig Jofré, S.A.

Active Ingredients

Tazobactam sodium 536.6mg eqv Tazobactam

500mg

Tazobactam

Piperacillin Sodium 4.17g eqv Piperacillin

4g

Piperacillin

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

SALATAZ POWDER FOR SOLUTION FOR INJECTION/INFUSION 4.5G/VIAL - HSA Approval | MedPath